"Fox Chase Cancer Center offers dermatology (including Mohs surgery) and urology services at its outpatient facility conveniently located on Huntingdon Pike in Rockledge, PA."

During the past decade, Fox Chase Cancer Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 3 trials, followed by "AbGenomics B.V Taiwan Branch" with 1 trials sponsored, "Fox Chase Cancer Center" with 1 trials sponsored, "Millennium Pharmaceuticals, Inc." with 1 trials sponsored and "Molecular Insight Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fox Chase Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fox Chase Cancer Center" are "Lymphoma" (2 trials), "Recurrent Uterine Sarcoma" (2 trials), "Stage III Uterine Sarcoma" (2 trials), "Stage IV Uterine Sarcoma" (2 trials) and "Uterine Carcinosarcoma" (2 trials). Many other conditions were trialed in "Fox Chase Cancer Center" in a lesser frequency.

Most popular intervention types in "Fox Chase Cancer Center" are "Drug" (8 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "vorinostat" (2 trials), "99mTc-MIP-1404 Injection" (1 trials), "AbGn-7" (1 trials), "Menadione Topical Lotion" (1 trials) and "TAK-901" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fox Chase Cancer Center" are 6 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fox Chase Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fox Chase Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fox Chase Cancer Center, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".